Stats

1 Alpaca primary docs distinguish cash-dividend adjustment from raw traded prices; asof is symbol mapping, not point-in-time vintage. https://docs.alpaca.markets/us/reference/stockbars .2 IWM issuer confirmsSep15ex .750436 paidSep18; EEM confirmsDec20,2023ex .748036. https://www.ishares.com/us/products/239710/ishares-russell-2000-etf ; https://www.ishares.com/us/products/239637/ishares-msci-emerging-markets-etf .3 Latest raw/all closes equal EEM67.03,QQQ721.45,IWM284.10: no current scalar conversion needed. IWM raw ATR3.25925 vsall3.217; twoATRstop difference .0845/share. EEM/QQQ ATR identical. Conclusion use adjusted mandate indicators and actual entry for brackets; raw gaps separately describe executable price risk. Distribution moves cash out of NAV to entitled holder; ownflat means no cash receivable. Counterexample vendor factors/rounding may not exactly equal issuer income; full adjustment reconciliation and QQQ payout schedule not established, do not invent amounts. Issuers earn fees; their distribution records are closer evidence than promotional performance.

Premises from issuer originals retrievedSep21: EEM Sep17 technology42.24%,Taiwan28.10%,Korea20.60%,China19.94%,PE19.40/PB2.69; Sep18 close67.03 matches bars. IWM Sep17 PE18.31/PB2.11,1957holdings; Aug31 beta1.24/volatility19.61%; Sep18 close284.10 agrees. QQQ Nasdaq100 nonfinancials, quarterly rebalance, annual reconstitution; dynamic holdings unavailable. EEM tech/Asia and QQQ growth exposure may share shocks; IWM smaller-business financing sensitivity is a hypothesis, not a quantified default forecast. Counterexamples: stronger earnings/export demand or improved domestic financing can support prices. Ratios alone establish neither overvaluation nor momentum veto. Issuers benefit from fund fees, so promotional commentary is not independent confirmation. Sources https://www.ishares.com/us/products/239637/ishares-msci-emerging-markets-etf ; https://www.ishares.com/us/products/239710/ishares-russell-2000-etf ; https://www.invesco.com/qqq-etf/en/about.html . No new weekend-event claims adopted from supplied headlines.

Premises: own ledger empty, so these are prospective exposures, not holdings. Issuer primary disclosures retrievedSep21: EEM Sep17 technology42.24%,Taiwan28.10%,Korea20.60%,China19.94%,PE19.40/PB2.69; IWM Sep17 PE18.31/PB2.11 and1957holdings,Aug31 beta1.24/volatility19.61%; QQQ tracks100largest Nasdaq nonfinancials, current weight widgets failed. Sources https://www.ishares.com/us/products/239637/ishares-msci-emerging-markets-etf ; https://www.ishares.com/us/products/239710/ishares-russell-2000-etf ; https://www.invesco.com/qqq-etf/en/about.html . Bear EEM: technology/Asian concentration permits common earnings and FX shock despite geographic label. Bear QQQ: large nonfinancial growth expectations can disappoint together, leaving long-lookback momentum late to reversal. Bear IWM: weaker financing/demand could pressure smaller businesses while only3.727% decline reaches SMA. These are conditional mechanisms, not measured new Sunday events or constituent balance-sheet claims. Counterarguments: exports/earnings may strengthen, QQQ cash generation may sustain prices, domestic recovery may support IWM. Issuer ratios alone prove neither overvaluation nor an entry veto. Brokers/issuers earn on participation; investor return still depends on price and cashflows. What changed today: completed crypto Sep20 and rolling target window; no new equity close. Weekend geopolitical headlines in context not independently corroborated here, therefore no causal trade conclusion. Fixed price rule remains long; no stop/target to reset on an empty book.

Premises:1 issuer cash distributions .763266 Dec16 2025/.350802 Jun15 2026 total1.114068/share;2 issuer hypothetical performance reinvests dividends/capital gains and deducts fund expenses;3 provider all adjusts dividend prices. Sources https://www.ishares.com/us/products/239637/ishares-msci-emerging-markets-etf and https://docs.alpaca.markets/us/reference/stockbars . These receipts explain why split-only25.8543% differs from total-return proxy28.3116%; cash payout is transferred value, not additional gain to add again to adjusted returns. Issuer benefits from fund inflows; cash dates/amounts useful independently of marketing. Counterexample: NAV total return differs from traded-market return due to fair value/premiums, and venue may not reinvest automatically. Therefore do not equate signal performance or price target with exact investor realized total return; retain mandate P90 calculation convention. Actual ledger cash credit treatment not verified this run.

Premises:1 EEM issuer Sep17 IT42.24%, Taiwan/Korea/China68.64%;2 IWM issuer Sep17 PE18.31 vs EEM19.40;3 QQQ issuer calls fund nondiversified and its dynamic holdings failed. Sources https://www.ishares.com/us/products/239637/ishares-msci-emerging-markets-etf ; https://www.ishares.com/us/products/239710/ishares-russell-2000-etf ; https://www.invesco.com/qqq-etf/en/about.html . EEM93.33 implies39.42USD IT,64.06USD in three domiciles. These are exposure measures, not independent cashflow valuations. Counterexample to cheapness inference: ETF PE conventions/populations may differ and omit loss-making earnings; a lower multiple does not set a defended price target. EEM issuer Sep18close67.03 agrees feed; NAV67.28 differs legitimately from exchange close, not proof of arbitrage. Sponsors benefit from inflows; do not borrow marketing diversification assurances. Fixed momentum/P90 targets govern, no value override or single-name substitution. Missing QQQ weights recorded as unknown.

Premises:1 issuer observations show EEM technology concentration and IWM healthcare/financial exposure;2 QQQ index excludes financial companies and issuer describes concentration risks;3 valuation ratios alone neither prove cheapness nor forecast cashflow. Inference: different labels do not remove shared equity/earnings sensitivity. Sponsor exposure descriptions are primary but commercially interested; no issuer-specific cashflow or earnings forecast invented. Ratios have different constituent profitability/mix and cannot establish relative-value edge. QQQ live holdings module unavailable: current weights unresolved, no reason to override recorded momentum. NAV versus close and different as-of dates reconcile apparent source mismatch. Sources https://www.ishares.com/us/products/239637/ishares-msci-emerging-markets-etf ; https://www.ishares.com/us/products/239710/ishares-russell-2000-etf ; https://www.invesco.com/qqq-etf/en/about.html . Fixed universe remains unchanged; no new fund justified.

Premises:1 Fed Sep18 AugustIP0%MoM/manufacturing-.3%,utilization76.3%;2 BLS payrolls increased4states and were essentially unchanged46+DC;3 these are agency estimates of August, not market expectations or ETF cash-flow forecasts. Fed JulyIP+.2% unchanged,June revised+.3 to+.2; output+1.4%YoY and manufacturing utilization75.7%. BLS national unemployment4.1%,state unemployment lower8+DC/stable42. Inference: manufacturing softness is a plausible IWM earnings risk, but broad stable payrolls and lower state unemployment resist a recession claim. Discount-rate easing could offset weaker earnings for QQQ; US activity alone cannot identify EEM local earnings/currency direction. Facts end at agency data; no valuation/earnings forecasts or Friday price causality established. Sources https://www.federalreserve.gov/releases/g17/current/ and https://www.bls.gov/news.release/laus.nr0.htm . This completes macro due384 in scope; NYFedNowcast not retrieved, no claim about it. No macro veto of fixed momentum.

Premises:1 ETF mandate admits only nine assets, so issuer events are context;2 verified calendars identify timings, not direction or surprise;3 no ownholding. Sep18 Fed G17 industrial production09:15ET/Bowman stress-testing09:30ET, BLS August state employment10ET, NYFed DSGE09ET/reserve-demand10ET/Nowcast12:45ET; CP13ET,H8/H15 16:15ET. Sep21 NYFed household spending11ET; CP13ET,H10/H15 16:15ET. Abivax issuer lists H1results Sep21 dateonly; outside universe, no direct entry. No verified Sep18 issuer earnings in bounded search. FDA page returned no rows, so Sep18/21 decisions unverified; no assertion calendar empty. Census no Sep18/21 match. These are scheduled events, not actual results or consensus surprises. Stronger realactivity can support earnings but raise rates; weakness can reduce earnings while lowering discount rates. Actual direction ambiguous, does not override fixed momentum. Sources https://www.federalreserve.gov/newsevents/2026-september.htm https://www.bls.gov/schedule/2026/09_sched.htm https://www.newyorkfed.org/research/calendars/i-sep26.html https://ir.abivax.com/events/event-details/h1-2026-financial-results/ https://www.fda.gov/advisory-committees/advisory-committee-calendar https://www.census.gov/economic-indicators/calendar-listview.html . Coverage limited, no new issuer valuation or causal return estimate claimed.

Premises:1 March18,2020 NYSE filing SEC34-88413 records March16 halt09:30:01 and15minute halt rules; auction reopening can take longer;2 local venue permits fractional exits onlyRTH with15minute checks;3 primary1Min bars show discontinuity around halt. Conclusion execution availability is a binding market-structure constraint, not solved merely by choosing liquid diversified ETFs. Existing issuer exposure analysis3051 remains dated background (QQQ nonfinancial concentration, IWM smallcaps, EFA overseas equities); no fresh constituent cash-flow or valuation claim and no fundamental veto. Who benefits: auction mechanisms aggregate liquidity, but holders bear interim repricing. Counterexample: liquid ordinary openings can execute quickly, matching small recent delay increments. Source https://www.sec.gov/files/rules/sro/nyse/2020/34-88413.pdf ; https://runway.adityaperswal.workers.dev/data/stock-bars ; https://docs.alpaca.markets/us/reference/stockbars .

Premises:1 QQQ issuer identifies Nasdaq100 nonfinancial concentration https://www.invesco.com/qqq-etf/en/about.html ;2 IWM broadUSsmallcap andclose288.89 https://www.ishares.com/us/products/239710/ishares-russell-2000-etf ;3 EFA international developed large/midcaps, Sep10 financials26.47%,industrials18.66%,Japan24.44%,PE19.16/PB2.37/658holdings; Sep11close106.70 https://www.ishares.com/us/products/239623/ishares-msci-eafe-etf . Issuer closes agreebars. Inference: EFA cyclical financial/industrial exposure can correlate with US risk despite overseas holdings. Counterexample: divergent earnings/FX may diversify ordinary periods; PE alone proves neither cheap nor expensive. QQQ growth expectations and IWM refinancing are conditional bear mechanisms, no new shock measured. Issuers benefit assetfees and emphasize products; no audited aggregate debt/cashflow or freshQQQweights obtained. Rule remains fixed; no fundamental veto.

Premises:1 own book has no holdings/trades;2 Issuer identifies developed large/mid caps outside US/Canada; Sep10 financials26.47%,industrials18.66%,Japan24.44%; Sep11 close106.70 matches bars. 3 fixed signal3000 remains eligible. Bear case: A global industrial slowdown plus adverse currency translation can lower USD equity returns while financial-sector losses amplify cyclical exposure. Conditional inference; no current FX or profit shock measured. Counterexample: Foreign equity strength and supportive currency moves could keep returns positive; diverse countries do not mean independent crisis returns. Who benefits: issuers collect asset-based fees; index inclusion does not establish cheap valuation. Source https://www.ishares.com/us/products/239623/ishares-msci-eafe-etf. Start flat, goal implement fixed complement, binding constraint RTH fractional execution. No fresh constituent cash-flow/valuation audit or verified Saturday event change; supplied news is unverified context and does not override rule. Cash-flow mechanism supports stress sizing, not a discretionary entry veto.

Premises:1 own book has no holdings/trades;2 Issuer identifies broad US small-cap Russell2000 exposure; Sep11 close288.89 matches bar feed. 3 fixed signal3000 remains eligible. Bear case: A credit tightening/recession shock can simultaneously weaken smaller-company revenues and raise refinancing expense. Debt sensitivity is a scenario inference, not an audited current aggregate leverage estimate. Counterexample: Easier financing and resilient domestic demand could sustain the trend; no verified new shock establishes failure. Who benefits: issuers collect asset-based fees; index inclusion does not establish cheap valuation. Source https://www.ishares.com/us/products/239710/ishares-russell-2000-etf. Start flat, goal implement fixed complement, binding constraint RTH fractional execution. No fresh constituent cash-flow/valuation audit or verified Saturday event change; supplied news is unverified context and does not override rule. Cash-flow mechanism supports stress sizing, not a discretionary entry veto.

Premises:1 own book has no holdings/trades;2 Issuer describes Nasdaq100 largest nonfinancial Nasdaq companies and nondiversified/sector concentration risk. Current holdings weights failed to render; no weight or valuation asserted. 3 fixed signal3000 remains eligible. Bear case: A reversal in expected growth or higher discount rates can hit concentrated long-duration profit expectations together. This is a conditional bear mechanism, not a measured fresh earnings downgrade. Counterexample: Persistent earnings growth can sustain momentum despite concentration. Concentration alone does not negate the positive fixed signal. Who benefits: issuers collect asset-based fees; index inclusion does not establish cheap valuation. Source https://www.invesco.com/qqq-etf/en/about.html. Start flat, goal implement fixed complement, binding constraint RTH fractional execution. No fresh constituent cash-flow/valuation audit or verified Saturday event change; supplied news is unverified context and does not override rule. Cash-flow mechanism supports stress sizing, not a discretionary entry veto.

Premises:1 QQQ tracks100 largest nonfinancial Nasdaq-listed companies (issuer https://www.invesco.com/qqq-etf/en/about.html );2 IWM tracks US small-cap equities (issuer prospectus https://www.ishares.com/us/literature/summary-prospectus/sp-ishares-russell-2000-etf-3-31.pdf );3 EFA tracks developed large/mid-cap equities outsideUS/Canada (issuer https://www.ishares.com/us/products/239623/ishares-msci-eafe-etf?qt=EFA ). ReadSept12 2026. These sources are primary for product design but commercially interested, and two iShares pages are one issuer family, not independent confirmations. Conclusion: economic exposures differ by company size, listing and geography, yet all remain long equity claims. Recorded gap correlations.779–.817 over2016–26 and common worstMar16 2020 contradict treating three labels as independent left tails. Inference: global discount-rate/liquidity shocks can strike all simultaneously; foreign trading hours/FX can transmit repricing into EFA's US opening. No claim of a specific present catalyst, current factor weight or causal regression. Counterexample to broad diversification: EFA's11.6235% crisis gap exceeded QQQ9.4572% andIWM9.3019%. No individual corporate filing, unit-economic forecast or ETF valuation edge is needed to implement the accepted fixed price rule; these structural facts support risk accounting, not an extra entry filter. Rank-based recommendation remains QQQ/IWM/EFA, with EEM excluded by Core trend queued order.